Showing results (91-100 of 156) with videos related to

Sort By:
Pageof 16
European Journal of Cancer (Oxford, England : 1990)|February 9, 2006
The association between Akt activation and resistance to hormone therapy in metastatic breast cancerEriko Tokunaga, Akemi Kataoka, Yasue Kimura, et al.
European Journal of Radiology|October 3, 2009
Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR imagesHidetake Yabuuchi, Yoshio Matsuo, Takeshi Kamitani, et al.
Environmental and Molecular Mutagenesis|June 11, 2024
Mutation spectra of the BRCA1/2 genes in human breast and ovarian cancer and germlineYumiko Koi, Arisa Watanabe, Akari Kawasaki, et al.
Breast Cancer (Tokyo, Japan)|July 5, 2018
CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapyEriko Tokunaga, Aya Fujita, Katsumi Takizawa, et al.
Surgery Today|April 9, 2013
Gender differences in prognosis after esophagectomy for esophageal cancerMasaru Morita, Hajime Otsu, Hiroyuki Kawano, et al.
Magnetic Resonance in Medical Sciences : MRMS : an Official Journal of Japan Society of Magnetic Resonance in Medicine|July 17, 2013
Correlations between apparent diffusion coefficient values and prognostic factors of breast cancerTakeshi Kamitani, Yoshio Matsuo, Hidetake Yabuuchi, et al.
Surgery Today|October 22, 2013
Early discontinuation of adjuvant hormone therapy is associated with a poor prognosis in Japanese breast cancer patientsKenji Taketani, Eriko Tokunaga, Nami Yamashita, et al.
Clinical Imaging|August 30, 2011
Diagnostic performance in differentiation of breast lesion on digital mammograms: comparison among hard-copy film, 3-megapixel LCD monitor, and 5-megapixel LCD monitorTakeshi Kamitani, Hidetake Yabuuchi, Yoshio Matsuo, et al.
Clinical Pharmacology and Therapeutics|September 27, 2022
Effect of Trastuzumab Deruxtecan on QT/QTc Interval and Pharmacokinetics in HER2-Positive or HER2-Low Metastatic/Unresectable Breast CancerAkihiko Shimomura, Toshimi Takano, Shunji Takahashi, et al.
Surgery Today|September 10, 2013
Impact of second-line and later cetuximab-containing therapy and KRAS genotypes in patients with metastatic colorectal cancer: a multicenter study in JapanHiroshi Saeki, Yasunori Emi, Ryuichi Kumashiro, et al.
Pageof 16